LabBulletin: New paper from Optibrium and Tessella illustrates scientists’ instincts are often impaired by human cognitive biases when making drug discovery decisions
Optibrium, a provider of software solutions for drug discovery, and Tessella, the information technology and consulting services company and world leaders in digital preservation technology, today published a new paper highlighting that scientists’ instincts may not always lead them to making good drug discovery decisions…read more
